Carvacrol had similar effects on PI3K/AKT/GLUT4 signaling in T2DM and T1DM mice, wherein it activated PI3K/AKT signaling and increased GLUT4 membrane translocation. The gene discussed is SLC2A4; the disease is type 1 diabetes mellitus.